ConductScience.org, home

Gene · 3191

NIH grants1,197

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleHNRNPL papersNewest fiscal year
R01NS125276The Role of NMD in Cortical Neural Progenitor Cells22025
R35GM118068Transcription regulation in chromatin22025
T32AI007363Immunobiology of Myeloid and Lymphoid Cells22025
U01AA01665811/11 Connectome-based fingerprinting of alcohol drinking in mice: mechanisms and biomarkers22025
ZIAAG000511Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis22025
ZIABC006150DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs22025
ZICBC011430CPTR - Mass Spectrometry Unit22025
F30CA278005Characterizing the RNA-mediated recruitment of histone deacetylases to chromatin12025
I01BX001584Molecular Manipulation to Enhance Anti-Myeloma Response12025
I01BX004848IGF2 causes DNA damage in liver cancer12025
IK6BX005224BLR&D Research Career Scientist Award Application12025
K08CA263552Deciphering non-canonical translation in high risk medulloblastoma12025
K12CA215110YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM12025
K12HD001259UC San Diego Womens Reproductive Health Research Program12025
K24AR060297Scleroderma Twin Study and analysis of Estrogen in patients with dcSSc12025
P01AI063302The intersection of innate and adaptive immunity to intracellular pathogens12025
P01AI150585Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus12025
P01CA013106Targeting Transcription and Splicing in Cancer12025
P01CA155258Integrative Oncogenomics of Multiple Myeloma12025
P01CA163205Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3191/grants?page=3